20060511
 Merck Study Finds A Vioxx Risk After Use Ended   By Ron Winslow, Heather Won Tesoriero and John Carreyrou, The Wall Street Journal,  May 12, 2006  Ken Frazier, Merck's general counsel, said the new data wouldn't change Merck's litigation strategy, which has been to fight each lawsuit on a case-by-case basis. The Whitehouse Station, N.J., company faces roughly 11,500 suits over Vioxx, which an estimated 20 million Americans took during the 4 1/2 years the drug was on the market. Of the six cases that have gone to trial, Merck has won three and lost three.   
